Morbidity and mortality associated with intraperitoneal chemotherapy for Pseudomyxoma peritonei.
about
Early and long-term postoperative management following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.Laparoscopic mucin removal in patients with pseudomyxoma peritonei.Perioperative intraperitoneal chemotherapy for peritoneal surface malignancyPseudomyxoma peritonei: disseminated peritoneal adenomucinosis variantA systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma.Incidence of leukopenia after intraperitoneal vs combined intravenous/intraperitoneal chemotherapy in pseudomyxoma peritonei.Incidence, risk factors, and impact of severe neutropenia after hyperthermic intraperitoneal mitomycin C.A comparison of hematologic toxicity profiles after heated intraperitoneal chemotherapy with oxaliplatin and mitomycin C.A pharmacological review on intraperitoneal chemotherapy for peritoneal malignancy.Pharmacokinetics and pharmacodynamics of intraperitoneal cancer chemotherapeutics.Adverse Events Postoperatively Had No Impact on Long-Term Survival of Patients Treated with Cytoreductive Surgery with Heated Intraperitoneal Chemotherapy for Appendiceal Cancer with Peritoneal Metastases.Mitomycin C Pharmacokinetics as Predictor of Severe Neutropenia in Hyperthermic Intraperitoneal Therapy.Factors Associated with 60-Day Readmission Following Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy.
P2860
Q34391061-31A09C46-61BC-4D26-927C-276EB8CDEC53Q34466382-FF206AC0-A2F8-4F2A-8A06-4BA8F16A17D7Q34690528-8C9B885F-0EFF-47F8-ACF4-2F6A6DE557F2Q34952261-B76811B2-7211-45A9-A169-7E1AB733214FQ36665886-3A410FC0-9551-4FB8-8B63-7EFADB629AF8Q37178748-CB7675F8-55AF-435F-AF4F-1F1D14150231Q37264971-999E2958-5186-4326-BC33-EA420EB0A13FQ37597149-76540C6C-6A6F-4F77-877D-812C406BD522Q37821289-09F723FF-881E-4273-8ABB-44D1F80EA092Q37993908-4CAA738C-FCF4-47E6-BDC3-9DD40FAA699DQ39659175-E8BD707A-82F8-42FE-A2FA-E4E2B2B8E7F4Q41649404-46B9C368-CEDB-42FC-B3A4-621519447FF1Q46989085-BFB70CF1-B51B-4841-8DE5-5387F059F3BB
P2860
Morbidity and mortality associated with intraperitoneal chemotherapy for Pseudomyxoma peritonei.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Morbidity and mortality associ ...... py for Pseudomyxoma peritonei.
@ast
Morbidity and mortality associ ...... py for Pseudomyxoma peritonei.
@en
type
label
Morbidity and mortality associ ...... py for Pseudomyxoma peritonei.
@ast
Morbidity and mortality associ ...... py for Pseudomyxoma peritonei.
@en
prefLabel
Morbidity and mortality associ ...... py for Pseudomyxoma peritonei.
@ast
Morbidity and mortality associ ...... py for Pseudomyxoma peritonei.
@en
P2093
P1476
Morbidity and mortality associ ...... py for Pseudomyxoma peritonei.
@en
P2093
Amil M Shah
David J Klaassen
Greg I McGregor
O Neely M Panton
Sonia A Butterworth
P304
P356
10.1016/S0002-9610(02)00843-7
P407
P577
2002-05-01T00:00:00Z